Identification and vaccine adjuvant responses of dendritic cells in humans

人类树突状细胞的鉴定和疫苗佐剂反应

• 批准号: 8292381
• 负责人: Sarah Jane Schlesinger
• 金额: $ 51.99万
• 依托单位: ROCKEFELLER UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-04-01 至 2012-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8292381
• 关键词: Address; Adjuvant; Agonist; Antibodies; Antigen-Presenting Cells; Area; B-Lymphocytes; Bacteria; Bar Codes; Blood; C Type Lectin Receptors; CD34 gene; CD8B1 gene; Cell Wall; Cell physiology; Cells; Complement; Dendritic Cell Pathway; Dendritic Cells; Development; Double-Stranded RNA; Epstein-Barr Virus Infections; Exposure to; Fetal Liver; Foundations; Funding; Grant; Granulocyte-Macrophage Colony-Stimulating Factor; Guidelines; HIV; HIV vaccine; Human; Immune response; Immune system; Immunity; Immunodeficient Mouse; Inbred NOD Mice; Individual; Inflammatory; Institutional Review Boards; Interleukin-2; Interleukin-4; Ligation; Link; Lymphoid; Lymphoid Tissue; Methods; Monkeys; Monoclonal Antibodies; Mus; Natural Immunity; Organ; Pathway interactions; Pattern recognition receptor; Phase; Poly I-C; Process; Proteins; Reporting; Research; Role; Spleen; Stress; System; T cell response; T-Lymphocyte; TLR4 gene; Testing; Tissues; Toxicology; Vaccination; Vaccine Adjuvant; Vaccines; Work; adaptive immunity; base; fighting; healthy volunteer; human subject; improved; in vivo; inflammatory marker; lymph nodes; meetings; microbial; monocyte; pathogen; progenitor; receptor; reconstitution; response; sound; uptake; vaccine development; volunteer